Pharming Group N.V (PHGUF PINK) stock market data APIs
$1.494
0(0%)
as of September 12, 2025
Try our APIs with
free plan!
Pharming Group N.V Financial Data Overview
Price chart is built with
Anychart
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Prev. Close
1.494
Open
1.494
High
1.494
Low
1.494
52 wk Range
0.745-1.5
Market Cap
1 028 M
Shares Outstanding
685 M
Revenue
340 M
EPS
0.0067
Beta
0.586
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pharming Group N.V data using free add-ons & libraries
Get Pharming Group N.V Fundamental Data
Pharming Group N.V Fundamental data includes:
- Net Revenue: 340 M
- EBITDA: 26 370 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pharming Group N.V News
New
Pharming Group promoted to the Euronext AMX® index
Pharming Group N.V. Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted fr...
Pharming Group names new finance head
* Pharming Group (PHAR [https://seekingalpha.com/symbol/PHAR]) appointed [https://seekingalpha.com/pr/20216757-pharming-group-appoints-kenneth-lynard-as-chief-financial-officer] Kenneth Lynard a...
Discovering Angler Gaming And 2 Other European Penny Stock Opportunities
The European market has recently seen a boost, with the pan-European STOXX Europe 600 Index climbing 1.18% amid easing trade tensions and optimism about U.S. interest rate cuts, contributing to positi...
Pharming Group N.V. GAAP EPS of $0.006, revenue of $93.2M
* Pharming Group N.V. press release [https://seekingalpha.com/pr/20184004-pharming-group-reports-second-quarter-and-first-half-2025-financial-results-and-provides] (OTCPK:PHGUF [https://seekingalpha...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
